Precision immunization: a new trend in human vaccination

References

• Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Jama. 2007;298(18):2155–63. doi:10.1001/jama.298.18.2155. PMID: 18000199.
   PubMed Web of Science ®Google Scholar
• Maldonado YA. Current controversies in vaccination: vaccine safety. Jama J Am Med Assoc. 2002;288(24):3155–58. doi:10.1001/jama.288.24.3155. PMID: 12495396.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States. 2019 [accessed 2019 February 5]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html
   Google Scholar
• Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States. 2019 [accessed 2019 February 5]. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html
   Google Scholar
• GOV.UK. Complete routine immunisation schedule [accessed 2019 July 12]. https://www.gov.uk/government/publications/the-complete-routine-immunisation-schedule
   Google Scholar
• Australian Government Dapartment of Health. The Australian immunisation handbook [accessed 2019 July 12]. https://immunisationhandbook.health.gov.au
   Google Scholar
• Ota MOC, Vekemans J, Schlegel-Haueter SE, Fielding, K., Whittle, H., Lambert, P H., McAdam, Keith P W J., Siegrist, C A., Marchant, A. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine. 2004;22(3):511–19. doi:10.1016/j.vaccine.2003.07.020. PMID: 14670334.
   PubMed Web of Science ®Google Scholar
• Weinberger B, Herndlerbrandstetter D, Schwanninger A, Weiskopf, D., Grubeck-Loebenstein, B., Linnik, J E., Egli, A. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis. 2008;46(7):1078–84. doi:10.1086/529197. PMID: 18444828.
   PubMed Web of Science ®Google Scholar
• Patricia P, Camila Q, Ana Lúcia SL, Zago C.A. and Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2011;2012(3):1–13. doi:10.1155/2012/985646. PMID: 22235228.
   Google Scholar
• Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol. 1998;22(1):2–14. PMID: 9523395.
   PubMed Web of Science ®Google Scholar
• Becky A, Claude L, Stuart MC. Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004;4(7):553–64. doi:10.1038/nri1394. PMID: 15229474.
   PubMed Web of Science ®Google Scholar
• Excler JL. Potentials and limitations of protein vaccines in infants. Vaccine. 1998;16(14–15):1439–43. doi:10.1016/S0264-410X(98)00105-4. PMID: 9711785.
   PubMed Web of Science ®Google Scholar
• Eskola J, Kayhty H, Takala AK, Peltola, H, Rönnberg, P R., Kela, E, Pekkanen, E, McVerry, P H., Mäkelä, P H. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med. 1990;323(20):1381–87. doi:10.1056/NEJM199011153232004. PMID: 2233904.
   PubMed Web of Science ®Google Scholar
• Gagneur A, Pinquier D, Quach C. Immunization of preterm infants. Hum Vaccin. 2015;11(11):2556–63. doi:10.1080/21645515.2015.1074358. PMID: 26291883.
   PubMed Web of Science ®Google Scholar
• Goronzy JRJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14(5):428–36. doi:10.1038/ni.2588. PMID: 23598398.
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159–69. doi:10.1016/j.vaccine.2005.08.105. PMID: 16213065.
   PubMed Web of Science ®Google Scholar
• Triglav TK, Poljak M. Vaccination indications and limits in the elderly. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(3):65–70. doi:10.2478/v10162-012-0037-9. PMID: 24089135.
   PubMedGoogle Scholar
• Diazgranados CA, Dunning AJ, Jordanov E, Landolfi, V., Denis, M., Talbot, H K. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009–2010 season. Vaccine. 2013;31(6):861–66. doi:10.1016/j.vaccine.2012.12.013. PMID: 23261045.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Treanor JJ, Tornieporth N, Capellan, J., Gorse, G J. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009;200(2):172–80. doi:10.1086/599790. PMID: 19508159.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Licensure of a high-dose inactivated influenza vaccine for persons aged ≥65 years (fluzone high-dose) and guidance for use—United States, 2010. MMWR Morb Mortal Wkly Rep. 2010;59(16):485–86. PMID: 20431524.
   PubMedGoogle Scholar
• Mannino S, Villa M, Apolone G, Weiss, N S., Groth, N., Aquino, I., Boldori, L., Caramaschi, F., Gattinoni, A., Malchiodi, G., et.al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in Northern Italy. Am J Epidemiol. 2012;176(6):527–33. doi:10.1093/aje/kws313. PMID: 22940713.
   PubMed Web of Science ®Google Scholar
• Frey SE, Reyes MR, Reynales H, Bermal, N N., Nicolay, U., Narasimhan, V., Forleo-Neto, E., Arora, A K. Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 2014;32(39):5027–34. doi:10.1016/j.vaccine.2014.07.013. PMID: 25045825.
   PubMed Web of Science ®Google Scholar
• Mcelhaney JE, Beran J, Devaster JM, Esen, M., Launay, O., Leroux-Roels, G., Ruiz-Palacios, G M., van Essen, G A., Caplanusi, A., Claeys, C., et.al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis. 2013;13(6):485–96. doi:10.1016/S1473-3099(13)70046-X. PMID: 23518156.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Leroux-Roels G, Beran J, Devaster JM, Esen M, Launay O, Mcelhaney JE, van Essen GA, Benoit A, et al. Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: a phase 3, randomized trial and post-hoc correlate of protection analysis. Hum Vaccin Immunother. 2016;12(12):3043–55. doi:10.1080/21645515.2016.1219809. PMID: 27690762.
   PubMed Web of Science ®Google Scholar
• Himal L, Cunningham AL, Olivier G, Chlibek, R., Diez-Domingo, J., Hwang, S-J., Levin, M J., McElhaney, J E., Poder, A., Puig-Barberà, J., et.al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96. doi:10.1056/NEJMoa1501184. PMID: 25916341.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díezdomingo J, Godeaux O, Levin MJ, Mcelhaney JE, Puigbarberà J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019–32. doi:10.1056/NEJMoa1603800. PMID: 27626517.
   PubMed Web of Science ®Google Scholar
• Tricco AC, Zarin W, Cardoso R,Veroniki AA, Khan PA, Nincic V, Ghassemi M, Warren R, Sharpe JP, Page AV, et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ. 2018;363:k4029. doi:10.1136/bmj.k4029. PMID: 30361202.
   PubMedGoogle Scholar
• Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine. 2008;26(29):3551–55. doi:10.1016/j.vaccine.2008.04.054. PMID: 18524433.
   PubMed Web of Science ®Google Scholar
• Stanberry LR, Spruance SL, Cunningham AL, Bernstein, D I., Mindel, A., Sacks, S., Tyring, S., Aoki, F Y., Slaoui, M., Denis, M., Vandepapeliere, P., Dubin, G. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med. 2002;347(21):1652–61. doi:10.1056/NEJMoa011915. PMID: 12444179.
   PubMed Web of Science ®Google Scholar
• Cook IF. Sex differences in injection site reactions with human vaccines. Hum Vaccin. 2009;5(7):441–49. doi:10.4161/hv.8476. PMID: 19377279.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Luedtke A, Langevin E, Zhu, M., Bonaparte, M., Machabert, T., Savarino, S., Zambrano, B., Moureau, A., Khromava, A., et.al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018;379(4):327–40. doi:10.1056/NEJMoa1800820. PMID: 29897841.
   PubMed Web of Science ®Google Scholar
• Li JX, Hou LH, Meng FY, Wu, S-P., Hu, Y-M., Liang, Qi, Chu, K., Zhang, Z., Xu, J-J., Tang, R., et.al. Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Glob Health. 2017;5(3):e324–e334. doi:10.1016/S2214-109X(16)30367-9. PMID: 28017642.
   PubMed Web of Science ®Google Scholar
• Monto AS, Malosh RE, Petrie JG, Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. J Infect Dis. 2017;215(12):1782–88. doi:10.1093/infdis/jix173. PMID:28398521.
   PubMed Web of Science ®Google Scholar
• Vatti A, Monsalve DM, Pacheco Y, Chang, C., Anaya, J-M., Gershwin, M E. Original antigenic sin: a comprehensive review. J Autoimmun. 2017;83:12–21. doi:10.1016/j.jaut.2017.04.008. PMID: 28479213.
   PubMed Web of Science ®Google Scholar
• Kirsi T, Leena H, Timo V, Blazevic, V. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype. Viral Immunol. 2013;26(2):167–70. doi:10.1089/vim.2012.0082. PMID: 23438469.
   PubMed Web of Science ®Google Scholar
• Pittman PR, Liu C-T, Cannon TL, Mangiafico, J A., Gibbs, P H. Immune interference after sequential alphavirus vaccine vaccinations. Vaccine. 2009;27(36):4879–82. doi:10.1016/j.vaccine.2009.02.090. PMID: 19576665.
   PubMed Web of Science ®Google Scholar
• Adam T, Suan-Sin F, Roberto B, Dinh, L V., King, Nicholas J C., Mahalingam, S.Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. 2015;268(1):340–64. doi:10.1111/imr.12367. PMID: 26497532.
   PubMed Web of Science ®Google Scholar
• Saco TV, Strauss AT, Ledford DK. Hepatitis B vaccine non-responders: possible mechanisms and solutions. Ann Allergy Asthma Immunol. 2018;121(3):320–27. doi:10.1016/j.anai.2018.03.017. PMID: 29567355.
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol. 2004;65(12):1506–15. doi:10.1016/j.humimm.2004.07.001. PMID: 15603879.
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Schaid DJ. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine. 2001;20(3):430–38. doi:10.1016/S0264-410X(01)00346-2. PMID: 11672906.
   PubMed Web of Science ®Google Scholar
• Chengbin W, Jianming T, Wei S, Lobashevsky, E., Wilson, C M., Kaslow, R A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology. 2004;39(4):978–88. doi:10.1002/hep.20142. PMID: 15057902.
   PubMed Web of Science ®Google Scholar
• Roh EY, Song EY, Yoon JH, Oh, S., Young Chang, Ju, Park, H., Hyun Seo, S., Shin, S. Effects of interleukin-4 and interleukin-12B gene polymorphisms on hepatitis B virus vaccination. Ann Hepatol. 2017;16(1):63–70. doi:10.5604/16652681.1226816. PMID: 28051794.
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Haralambieva IH, Vierkant RA, O’Byrne, M M., Jacobson, R M., Poland, G A. The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered. 2011;72(3):206–23. doi:10.1159/000331585. PMID: 22086389.
   PubMed Web of Science ®Google Scholar
• Jie C, Zhenglun L, Fengmin L, Fang, X., Liu, S., Zeng, Y., Zhu, F., Chen, X., Shen, T., Li, J., Zhuang, H. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine. 2011;29(4):706–11. doi:10.1016/j.vaccine.2010.11.023. PMID: 21111021.
   PubMed Web of Science ®Google Scholar
• Linnik JE, Egli A. Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin. 2016;12(4):907–15. doi:10.1080/21645515.2015.1119345. PMID: 26809773.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Irene PS, F Raúl V, Hector A, Thomas B, Sueann Costa C, Brigitte C, Felix E, Paul G, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa052434. PMID: 16394298.
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velázquez FR, Irene PS, Sáez-Llorens, X., Abate, H., Espinoza, F., López, P., Macías-Parra, M., Ortega-Barría, E., Rivera-Medina, D M., et.al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371(9619):1181–89. doi:10.1016/S0140-6736(08)60524-3. PMID: 18395579.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster, V, Tejedor, J C., Cohen, R, Meurice, F, Han, H H., Damaso, S, Bouckenooghe, A Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370(9601):1757–63. doi:10.1016/S0140-6736(07)61744-9. PMID: 18037080.
   PubMed Web of Science ®Google Scholar
• Timo V, Matson DO, Penelope D, Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M J., Heyse, J F., Goveia, M G., Black, S B., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa052664. PMID: 16394299.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Duncan S, Witte, D., Kirsten, M., Louw, C., Ngwira, B., Victor, J C., Gillard, P H., Cheuvart, B B., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–98. doi:10.1056/NEJMoa0904797. PMID: 20107214.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas, M J., Tapia, M D., Feikin, D R., Binka, F N., Steele, A D., Laserson, K F., Ansah, N A., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–14. doi:10.1016/S0140-6736(10)60889-6. PMID: 20692030.
   PubMed Web of Science ®Google Scholar
• Harris VC, Armah G, Fuentes S, Korpela, K E., Parashar, U., Victor, J C., Tate, J., de Weerth, C., Giaquinto, C., Wiersinga, W J., et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J Infect Dis. 2017;215(1):34–41. doi:10.1093/infdis/jiw518. PMID: 27803175.
   PubMed Web of Science ®Google Scholar
• Harris VC, Ali A, Fuentes S, Korpela, K., Kazi, M., Tate, J., Parashar, U., Wiersinga, W J., Giaquinto, C., de Weerth, C., et al. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan. Gut Microbes. 2018;9(2):93–101. doi:10.1080/19490976.2017.1376162.
   PubMed Web of Science ®Google Scholar
• Eloefadrosh EA, Mcarthur MA, Seekatz AM, Drabek, E F., Rasko, D A., Sztein, M B., Fraser, C M., Gilbert, J A. Impact of oral typhoid vaccination on the human gut microbiota and correlations with S. Typhi-specific immunological responses. PLoS One. 2013;8(4):e62026. doi:10.1371/journal.pone.0062026. PMID: 23637957.
   PubMed Web of Science ®Google Scholar
• Huda MN, Zachery L, Kalanetra KM, Rashid, M., Ahmad, S M., Raqib, R., Qadri, F., Underwood, M A., Mills, D A., Stephensen, C B. Stool microbiota and vaccine responses of infants. Pediatrics. 2014;134(2):e362–372. doi:10.1542/peds.2013-3937. PMID: 25002669.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Wang Y, Gu W, Zhu F. Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. Hum Vaccin Immunother. 2017;14(18):1–10. doi:10.1080/21645515.2017.1409316. PMID: 29261406.
   Google Scholar
• Zaman K, Eliza R, Arifeen SE, Rahman, M., Raqib, R., Wilson, E., Omer, S B., Shahid, N S., Breiman, R F., Breiman, R E., Steinhoff, M C. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555–64. doi:10.1056/NEJMoa0708630. PMID: 18799552.
   PubMed Web of Science ®Google Scholar
• Eick AA, Uyeki TM, Klimov A, Hall, H., Reid, R., Santosham, M., O’Brien, K L, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;66(2):104–11. doi:10.1001/archpediatrics.2010.192. PMID: 20921345.
   Google Scholar
• Regan AK, Moore HC, De KN, Omer, S B., Shellam, G., Mak, D B., Effler, P V, et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis. 2016;62(10):1221–27. doi:10.1093/cid/ciw082. PMID: 27033634.
   PubMed Web of Science ®Google Scholar
• Sheffield JS, Greer LG, Rogers VL, Roberts, S W., Lytle, H., McIntire, D D., Wendel, G D, et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol. 2012;120(3):532–37. doi:10.1097/AOG.0b013e318263a278. PMID: 22914461.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Pregnancy and vaccination Accessed 2016 July 11. https://www.cdc.gov/vaccines/pregnancy
   Google Scholar
• Fiore AE, Wasley A, Bell BP. Prevention of hepatitis a through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR–7):1–23. PMID: 16708058.
   Google Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter, M J., Bell, B P., Finelli, L., Rodewald, L E., Douglas, J M., Janssen, R S., Ward, J W. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55(RR–16):1–33. PMID: 17159833.
   PubMedGoogle Scholar
• Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez, I R., Briere, E Z., Meissner, H C., Baker, C J., Messonnier, N E, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR–2):1–28. PMID: 23515099.
   PubMed Web of Science ®Google Scholar
• Kim DK, Bridges CB, Harriman KH. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older–United States, 2015. MMWR Recomm Rep. 2015;64(4):91–92. PMID: 25654609.
   Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson, H W., Chesson, H., Unger, E R, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR–2):1–23. PMID: 17380109.
   PubMedGoogle Scholar
• Badell ML, Meaney-Delman D, Tuuli MG, Rasmussen, S A., Petersen, B W., Sheffield, J S., Beigi, R H., Damon, I K., Jamieson, D J. Risks associated with smallpox vaccination in pregnancy. Obstet Gynecol. 2015;125(6):1439–51. doi:10.1097/AOG.0000000000000857. PMID: 26000516.
   PubMed Web of Science ®Google Scholar
• Charshafian S, Liang SY. Infectious disease emergencies in patients with cancer: rapid fire. Emerg Med Clin North Am. 2018;36(3):493–516. doi:10.1016/j.emc.2018.04.001. PMID: 30037437.
   PubMed Web of Science ®Google Scholar
• Sodhi JS, Raja W, Zargar SA, Showkat, A., Parveen, S., Nisar, S., Wani, M A., Javid, G., Khan, M., Aejaz, S., et al. The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy. Indian J Gastroenterol. 2015;34(5):372–79. doi:10.1007/s12664-015-0595-y. PMID: 26531066.
   PubMed Web of Science ®Google Scholar
• Leung TF, Li CK, Hung ECW, Chan, Paul K. S., Mo, C-W., Wong, Raymond P. O., Chik, K-W. Immunogenicity of a two‐dose regime of varicella vaccine in children with cancers. Eur J Haematol. 2015;72(5):353–57. doi:10.1111/j.1600-0609.2004.00216.x. PMID: 15059071.
   Google Scholar
• Alexander KE, Tong PL, Macartney K, Beresford, R., Sheppeard, V., Gupta, M. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection ☆. Vaccine. 2018;36(27):3890–93. doi:10.1016/j.vaccine.2018.05.078. PMID: 29807711.
   PubMed Web of Science ®Google Scholar
• Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348(6230):69–74. doi:10.1126/science.aaa4971. PMID: 25838375.
   PubMed Web of Science ®Google Scholar
• Ott PA, Hu Z, Keskin DB, Shukla, S A., Sun, J., Bozym, D J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547(7662):217–21. doi:10.1038/nature22991. PMID: 28678778.
   PubMed Web of Science ®Google Scholar
• Sahin U, Derhovanessian E, Miller M, Kloke, B-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A D., Luxemburger, U., Schrörs, B., et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547(7662):222–26. doi:10.1038/nature23003. PMID: 28678784.
   PubMed Web of Science ®Google Scholar
• Low A, Gavriilidis G, Larke N, B-Lajoie, M-R., Drouin, O., Stover, J., Muhe, L., Easterbrook, P. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(12):1595–603. doi:10.1093/cid/ciw125. PMID: 26951573.
   PubMed Web of Science ®Google Scholar
• Launay O, Van DDV, Rosenberg AR, Michel, M-L., Piroth, L., Rey, D., Colin de Verdière, N., Slama, L., Martin, K., Lortholary, O., et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. Jama J Am Med Assoc. 2011;305(14):1432–40. doi:10.1001/jama.2011.351. PMID: 21486976.
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Pelton SI, Song LY, Fenton, T., Levin, M J., Nachman, S A., Borkowsky, W., Rosenblatt, H M., Marcinak, J F., Dieudonne, A., Abrams, E J.et al. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatric Infect Dis J. 2006;25(10):920–29. doi:10.1097/01.inf.0000237830.33228.c3. PMID: 17006288.
   PubMed Web of Science ®Google Scholar
• Scott P, Moss WJ, Gilani Z, Low, N. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis. 2011;204(Suppl 1(Supplement 1)):S164–178. doi:10.1093/infdis/jir071. PMID: 21666158.
   PubMedGoogle Scholar
• Belaunzarán-Zamudio PF, García-León ML, Wong-Chew RM, Villasís-Keever, A., Cuellar-Rodríguez, J., Mosqueda-Gómez, J L., Muñoz-Trejo, T., Escobedo, K., Santos, J I., Ruiz-Palacios, G M., et al. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART. Vaccine. 2009;27(50):7059–64. doi:10.1016/j.vaccine.2009.09.063. PMID: 19799846.
   PubMed Web of Science ®Google Scholar
• Taweesith W, Puthanakit T, Kowitdamrong E, Bunupuradah, T., Wongngam, W., Phasomsap, C., Apornpong, T., Bouko, C., Pancharoen, C. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Pediatric Infect Dis J. 2011;30(4):320–24. doi:10.1097/INF.0b013e3181fe0868. PMID: 20975615.
   PubMed Web of Science ®Google Scholar
• Shafran S. Live attenuated herpes zoster vaccine for HIV‐infected adults. HIV Med. 2016;17(4):305–10. doi:10.1111/hiv.12311. PMID: 26315285.
   PubMed Web of Science ®Google Scholar
• Sanjay R, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010;23(4):740–80. doi:10.1128/CMR.00048-09. PMID: 20930072.
   PubMed Web of Science ®Google Scholar
• Breukels MA, Zandvoort A, Dobbelsteen GP, van den Muijsenberg, A., Lodewijk, M E., Beurret, M., Klok, P A., Timens, W., Rijkers, G T. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides. Infect Immun. 2001;69(12):7583–87. doi:10.1128/IAI.69.12.7583-7587.2001. PMID: 11705936.
   PubMed Web of Science ®Google Scholar
• Papadatou I, Orthopoulos G, Theodoridou M, Spoulou, V Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with β-thalassemia major. Vaccine. 2015;33(32):3779–83. doi:10.1016/j.vaccine.2015.06.100. PMID: 26144903.
   PubMed Web of Science ®Google Scholar
• Rezai MS, Ghaffari J, Mahdavi M, Bahari, A., Ala, S. Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: a randomized clinical trial study. Caspian J Intern Med. 2017;8(1):16–22. PMID: 28503278.
   PubMed Web of Science ®Google Scholar
• Nuorti JP, Whitney CG. Prevention of pneumococcal disease among infants and children — use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:(RR-11):1–18. PMID: 21150868.
   PubMedGoogle Scholar
• Bennett NM, Whitney CG, Moore M, Pilishvili T, Dooling KL. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Am J Transplant. 2013;13(1):232–35. doi:10.1111/ajt.12073. PMID: 23051612.
   Web of Science ®Google Scholar
• Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma, D H., Rijkers, G T. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29(4):675–80. doi:10.1016/j.vaccine.2010.11.034. PMID: 21115060.
   PubMed Web of Science ®Google Scholar
• Mikoluc B, Motkowski R, Käyhty H, Heropolitanska-Pliszka, E., Pietrucha, B., Bernatowska, E. Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomy. Eur J Clin Microbiol Infect Dis. 2012;31(5):805–09. doi:10.1007/s10096-011-1378-8. PMID: 21874399.
   PubMed Web of Science ®Google Scholar
• Chong PP, Avery RK. A comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients. Clin Ther. 2017;39(8):1581–98. doi:10.1016/j.clinthera.2017.07.005. PMID: 28751095.
   PubMed Web of Science ®Google Scholar
• Feng Y, Shi X, Shi J, Gao, L., Liu, G., Cheng, Y., Pan, M., Li, C., Wang, J., Guo, X., et al. Immunogenicity, antibody persistence, and safety of the 60 mug hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial. Expert Rev Vaccines. 2017;16(10):1045–52. doi:10.1080/14760584.2017.1367667. PMID: 28803502.
   PubMed Web of Science ®Google Scholar
• Kong NCT, Beran J, Kee SA, Miguel, J L., Sánchez, C, Bayas, J-M., Vilella, A, Calbo-Torrecillas, F, López de Novales, E, Srinivasa, K, Stoffel, M, et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int. 2008;73(7):856–62. doi:10.1038/sj.ki.5002725. PMID: 18160963.
   PubMed Web of Science ®Google Scholar
• Tong NKC, Jiri B, Swee Ann K, Miguel, J L., Sánchez, C., Bayas, J M., Vilella, A, de Juanes, J R., Arrazola, P, Calbo-Torrecillas, F., et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 2005;68(5):2298–303. doi:10.1111/j.1523-1755.2005.00689.x. PMID: 16221232.
   PubMed Web of Science ®Google Scholar
• Liao Z, Xu X, Liang Y, Xiong, Y., Chen, R., Ni, J. Effect of a booster dose of influenza vaccine in patients with hemodialysis, peritoneal dialysis and renal transplant recipients: a systematic literature review and meta-analysis. Hum Vaccin. 2016;12(11):2909–15. doi:10.1080/21645515.2016.1201623. PMID: 27392026.
   PubMed Web of Science ®Google Scholar
• Collins FS, Harold V. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–95. doi:10.1056/NEJMp1500523. PMID: 25635347.
   PubMed Web of Science ®Google Scholar
• Varghese L, Curran D, Bunge E, Vroling, H, van Kessel, F, Guignard, A, Casabona, G, Olivieri, A Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK. Public Health. 2017;142:46–49. doi:10.1016/j.puhe.2016.10.013. PMID: 28057197.
   PubMed Web of Science ®Google Scholar
• Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR–7):1–11. PMID: 12437192.
   Google Scholar
• Christian H. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature. Expert Rev Vaccines. 2014;13(3):399–415. doi:10.1586/14760584.2014.883285. PMID: 24512188.
   PubMed Web of Science ®Google Scholar
• Lindstrom V, Aittoniemi J, Salmenniemi U, Kayhty H, Huhtala H, Sinisalo M, Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia. Hum Vaccin Immunother. 2019;1–4. doi:10.1080/21645515.2019.1627160. PMID: 31216225.
   PubMed Web of Science ®Google Scholar